Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Closed-loop insulin delivery-the path to physiological glucose control.

G M Steil1, A E Panteleon, K Rebrin

  • 1Medtronic MiniMed Department, Sensor R&D, 18000 Devonshire St., Northridge, CA 91325-1219, USA.

Advanced Drug Delivery Reviews
|January 27, 2004
PubMed
Summary

This review explores artificial pancreas technology for diabetes management. It evaluates algorithms against natural insulin secretion, aiming to replicate healthy glucose levels for improved patient outcomes.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The artificial pancreas: evaluating risk of hypoglycaemia following errors that can be expected with prolonged at-home use.

Diabetic medicine : a journal of the British Diabetic Association·2015
Same author

Interstitial fluid glucose dynamics during insulin-induced hypoglycaemia.

Diabetologia·2005
Same author

Modeling insulin action for development of a closed-loop artificial pancreas.

Diabetes technology & therapeutics·2005
Same author

Can interstitial glucose assessment replace blood glucose measurements?

Diabetes technology & therapeutics·2001
Same author

High glucose stimulates early response gene c-Myc expression in rat pancreatic beta cells.

The Journal of biological chemistry·2001
Same author

Gene expression of VEGF and its receptors Flk-1/KDR and Flt-1 in cultured and transplanted rat islets.

Transplantation·2001

Area of Science:

  • Biomedical Engineering
  • Endocrinology
  • Diabetes Technology

Background:

  • Insulin-dependent diabetes requires continuous glucose monitoring and insulin delivery.
  • Artificial pancreas systems aim to automate glucose control, mimicking physiological insulin secretion.
  • Beta-cell function, including first- and second-phase insulin release, is crucial for normal glucose tolerance.

Purpose of the Study:

  • To review historical and recent advancements in artificial pancreas technology.
  • To evaluate existing algorithms for their ability to replicate healthy glucose and insulin profiles.
  • To compare artificial pancreas algorithms with the natural secretory response of pancreatic beta cells.

Main Methods:

  • Review of historical algorithms and technological progress in artificial pancreas development.

Related Experiment Videos

  • Analysis of beta-cell physiology relevant to glucose homeostasis.
  • Evaluation of closed-loop system data using continuous glucose sensors and insulin pumps.

    • Main Results:

    • Algorithms are assessed based on their capacity to mimic physiological insulin secretion patterns.
    • Comparison of artificial pancreas performance against the beta-cell's first- and second-phase insulin responses.
    • Presentation of experimental closed-loop data from integrated sensor-pump systems.

    Conclusions:

    • Artificial pancreas development is a critical goal for improving diabetes care.
    • Algorithm design must consider the nuances of natural insulin secretion for optimal efficacy.
    • Further research and technological integration are essential for advancing artificial pancreas systems.